Chinese healthcare platform 111 Inc's Q3 revenue drops amid model shift

Reuters12-17
Chinese healthcare platform 111 Inc's Q3 revenue drops amid model shift

Overview

  • Chinese healthcare platform's Q3 revenue fell 16.7% yr/yr amid strategic business model shift

  • Company achieved non-GAAP net profitability and positive operating cash flow

  • Company divested three subsidiaries, transitioning to asset-light model

Outlook

  • Company plans to build AI-powered transaction platform for pharmaceutical procurement

  • 111 Inc expects asset-light model to strengthen liquidity and profitability

  • Company sees growth in fulfillment network and supply chain capabilities

Result Drivers

  • ASSET-LIGHT TRANSITION - Co divested three subsidiaries to shift towards an asset-light model, improving profitability and liquidity

  • SUPPLY CHAIN ENHANCEMENTS - Ongoing "MANTIANXING" initiative improved supply chain capabilities, increasing GMV and customer count

Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q3 Revenue

RMB 3 bln

Q3 Adjusted Net Income

RMB 1.1 mln

Q3 Net Income

-RMB 1.50 mln

Q3 Adjusted Income From Operations

RMB 0.2 mln

Q3 Income From Operations

-RMB 2.30 mln

Q3 Operating Expenses

RMB 180.30 mln

Press Release: ID:nPn3VmmMha

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment